India's digital public infrastructure has delivered mixed results. What separates runaway successes like Aadhaar and UPI from ...

The Touchstone International Value Fund (Class A) outperformed its benchmark Index, for the quarter ended March 31, 2025.

Investors target stocks that have been on a bullish run lately. Stocks like DB, JNPR, ATRO and FHI are seeing price strength ...

What Happened: Herrero's recent move, as outlined in a Form 4 filing with the U.S. Securities and Exchange Commission on ...

Avoid harmful business tips like passive income myths and hustle culture. Learn what works for first-time entrepreneurs in ...

Simultaneous Growth in Scale and Profit of Ly.com Underscores the Potential of Mass-market Tourism . In Q1 2025, ly.com ...

Niagen Bioscience shares are trading up 2.54% at $13.75 at the time of this writing on Thursday morning. Since the current price is $13.75, this makes Cohen's 0 shares worth $0.

“Let’s be real, we are entering a phase of urban development that most ma-and-pa investors can’t keep up with. That doesn’t mean they are shut out of the game (and gains), it just means that for these ...

Lucid is following Tesla’s early playbook, targeting the luxury EV segment and expanding with the help of Saudi backing.

Labor insists its program to allocate $400,000 to each electorate is an anti-pork-barrelling grants scheme. But questions ...

Another management priority is to deleverage the balance sheet to around 5-6 times net debt/EBITDA by 2027, which is welcome, given that Cellnex's leverage is currently above peers'.